AGNG
Global X Aging Population ETF
Global X Longevity Thematic ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the Indxx Global Longevity Thematic Index.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
69.5 M
ASSETS UNDER MGMT
50 bp
EXPENSES
Fund Basics
| Fund sponsor | Global X |
| Category | Global |
| Asset class | Equity |
| Website | link... |
| Inception date | May 09, 2016 |
| Assets (mns) | $70 |
| Expense ratio | 50 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Annually |
| Taxation | 1099 |
| Stock selection | Proprietary |
| Weighting | Market Cap |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| UCB SA | 4.2 % |
| WELLTOWER, INC. | 3.5 % |
| ASTRAZENECA PLC-SPONS ADR | 3.3 % |
| ELI LILLY & CO | 3.2 % |
| ABBVIE INC | 3.2 % |
| EDWARDS LIFESCIENCES CORP | 3.2 % |
| JOHNSON & JOHNSON | 3.2 % |
| REGENERON PHARMACEUTICALS | 3.0 % |
| AMGEN INC | 2.9 % |
| MEDTRONIC PLC | 2.9 % |
Constituent Breakdown
| Number of holdings | 80 |
| Herfindahl-Hirschman Index | 219 |
| Wgt avg mkt cap (mns) | $106,872 |
| Large cap (>$10bn) | 85.9% |
| Mid cap ($2-10bn) | 8.7% |
| Small cap (<$2bn) | 5.4% |
| Developed mkts. | 92.1% |
| Emerging mkts. | 8.0% |
Country Exposure
 |
UNITED STATES | 54.7 % |
 |
SWITZERLAND | 10.2 % |
 |
JAPAN | 6.4 % |
 |
CHINA | 5.9 % |
 |
BRITAIN | 5.0 % |
 |
BELGIUM | 4.5 % |
 |
DENMARK | 4.1 % |
 |
IRELAND | 2.9 % |
 |
SOUTH KOREA | 2.2 % |
 |
GERMANY | 1.1 % |
Historical Performance
Standardized Performance (as of 10/31/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.1% | 5.7% | 16.5% | 10.8% | 6.7% | -- | -- | 8.7% |
| Dividend Yield | 0.5% | 1.0% | 1.0% | 0.9% | 0.8% | -- | -- | 0.9% |
| Total Returns | 12.6% | 6.7% | 17.5% | 11.6% | 7.5% | -- | -- | 9.6% | Ann. Volatility | 16.3% | 15.7% | 13.9% | 13.7% | 15.3% | -- | -- | 17.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.69 | 53% |
| MSCI EAFE | 0.63 | 58% |
| MSCI Emg Mkts | 0.44 | 33% |
Liquidity Measures
| Avg. volume (000) | 9 |
| ADV traded (mns) | $0 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.39% |
Technical Indicators
| Recent close | $34.09 |
| 30d moving avg. | $34.01 |
| Annualized volatility | 12.3% |
| Relative strength (RSI) | 55 |
| Short interest | 2.4% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. |
Expenses vs. |
ALTAR Score™ vs. |
|---|---|---|---|---|
| HRTS | Tema Heart & Health ETF | 32.1% | +25 bp | +2.3% |
| BMED | Future Health ETF | 31.2% | +35 bp | +0.3% |
| IXJ | iShares Global Healthcare ETF | 29.5% | -8 bp | +7.0% |
| IYH | iShares U.S. Healthcare ETF | 29.0% | -10 bp | +6.6% |
| XLV | The Health Care Select Sector SPDR Fund | 28.1% | -42 bp | +7.4% |
| VHT | Vanguard Health Care ETF | 28.1% | -41 bp | +5.8% |
| FHLC | Fidelity MSCI Health Care Index ETF | 28.0% | -42 bp | +6.0% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 26.2% | +10 bp | +8.8% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 24.5% | -10 bp | +8.0% |
| MDEV | First Trust Indxx Medical Devices ETF | 23.4% | +20 bp | +4.8% |
Risk and Returns: AGNG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2024 | 2025 | 2026 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/9/2025
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
NEUTRAL
Average appreciation potential. A rating of NEUTRAL is assigned to ETFs with ALTAR Scores in the middle quintile (ranking between 40%-60%) of their category. This indicates that valuations adequately reflect the fundamentals of stocks in these funds.
ALTAR Score™
AGNG
4.8%
Cat. Avg
4.3%
ALTAR Score™ Calculation
Category Overview
There are 371 funds in the Global Equity category, with an average ALTAR Score™
of 4.3% and a standard deviation of
3.2%. AGNG's ALTAR Score™ is approximately
0.2 standard deviations
above
the category average. This places AGNG in the 56th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
AGNGSELL
U/W
HOLD
O/W
BUY